METHOD FOR PRODUCING SHAPED BODIES FOR LITHIUM ION BATTERIES
    14.
    发明申请
    METHOD FOR PRODUCING SHAPED BODIES FOR LITHIUM ION BATTERIES 审中-公开
    用于生产形体用于锂离子电池

    公开(公告)号:WO1998044576A1

    公开(公告)日:1998-10-08

    申请号:PCT/EP1998001763

    申请日:1998-03-25

    Abstract: The invention relates to a method for producing shaped bodies, preferably for a film-like shaped body, comprising the following steps: I) compounding and melt extrusion of a mixture (I) comprising a mixture (II) containing a) 1 to 95 wt. % of at least a pigment (III) with a primary particle size ranging from 5 nm to 20mm, selected from the group consisting of one electrochemically inert solid (IIIa), of a compound (IIIb) capable of giving off lithium ions when charged, and a compound (IIIc), capable of receiving lithium ions when charged, and a mixture of solid (IIIa) with compounds (IIIb) or compound (IIIc), b) 5 to 99 wt. % of at least one polymer binding agent (IV), and c) 0 to 200 wt. % of at least one softening agent (V) in relation to the overall amount of constituents a) and b), wherein the weight percentage of mixture (II) in mixture (I) ranges from 1 to 100 wt. %, and excluding mixtures (I) comprising mixtures (II) containing a copolymer consisting of vinylidene fluoride (Vdf) and hexafluoropropylene (HFP) with a HFP content ranging from 8 to 25 wt. % as a polymer binding agent (IV) and a compound as a softening agent (V) which is selected from the group consisting of dibutyl phthalate, dimethyl phthalate, diethyl phthalate, tris(butoxy)ethyl phosphate, propylene carbonate, ethylene carbonate, trimethyl trimellitate and mixtures thereof.

    Abstract translation: 一种用于生产模塑制品,优选的片状成型体的过程中,以下步骤包括:I)混炼和熔化混合物(I的挤出),其包含(ii)含有的混合物:a)1至95重量%的至少一种颜料的 (III),其能够具有5纳米至20毫米的初级颗粒尺寸,其是从由电化学惰性固体(IIIa)中的基团,一个能够加载用于排出锂离子的化合物(IIIb)的和装载用于接收锂离子的 化合物(IIIc)中,将固体(IIIa)中的混合物中与化合物(IIIb)的化合物或该化合物(IIIc)中,b)5〜99重量%的至少一种聚合物粘合剂(IV),的%和c)0至200重量 .-%,基于组分a)和b),至少一种增塑剂V的总量,其特征在于,所述混合物(I)的比例(重量)的混合物(II)为1〜100重量%,并且其中的混合物(I) 包含含有的混合物(II) altend作为聚合物粘合剂(IV)为偏二氟乙烯(VdF)和六氟丙烯(HFP),其具有的8-25重量%的HFP含量的共聚物,和增塑剂(V)为选自邻苯二甲酸二丁酯组成的组中选择的化合物 ,邻苯二甲酸二甲酯,邻苯二甲酸二乙酯,三(丁氧基)乙酯,碳酸丙烯酯,碳酸乙烯酯,三甲基和它们的混合物被排除在外。

    DRUG FORMULATIONS
    16.
    发明申请
    DRUG FORMULATIONS 审中-公开
    药物制剂

    公开(公告)号:WO2012061779A1

    公开(公告)日:2012-05-10

    申请号:PCT/US2011/059456

    申请日:2011-11-04

    CPC classification number: A61K9/2077 A61K9/146 A61K9/2054

    Abstract: In one embodiment, the present invention relates to abuse-deterrent drug formulations comprise a plurality of discrete domains uniformly dispersed in a pharmaceutically acceptable matrix, wherein said domains have high fracture toughness and comprise at least one polymer and at least one abuse-relevant drug. In another embodiment, the present invention relates to a formulation comprising a plurality of discrete mechanically reinforcing particles uniformly dispersed in a pharmaceutically acceptable matrix, wherein said matrix has high fracture toughness and comprises at least one polymer and at least one active agent, at least one abuse-relevant drug or a combination of at least one active agent and at least one abuse-relevant drug.

    Abstract translation: 在一个实施方案中,本发明涉及滥用 - 威慑药物制剂包含均匀分散在药学上可接受的基质中的多个离散区域,其中所述区域具有高断裂韧性并且包含至少一种聚合物和至少一种滥用相关药物。 在另一个实施方案中,本发明涉及包含均匀分散在药学上可接受的基质中的多个离散的机械增强颗粒的制剂,其中所述基质具有高断裂韧性,并且包含至少一种聚合物和至少一种活性剂,至少一种 滥用相关药物或至少一种活性剂和至少一种滥用相关药物的组合。

    FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS
    17.
    发明申请
    FORMULATIONS OF NONOPIOID AND CONFINED OPIOID ANALGESICS 审中-公开
    非对称性和限制性阿片类药物的制剂

    公开(公告)号:WO2009014534A1

    公开(公告)日:2009-01-29

    申请号:PCT/US2007/073957

    申请日:2007-07-20

    Abstract: The preferred exemplary embodiments in the present application provide formulations and methods for the delivery of drugs, particularly drugs of abuse, having an abuse-relevant drug substantially confined in the core and a non-abuse relevant drug in a non-core region. These formulations have reduced potential for abuse. In the formulation, preferably the abuse relevant drug is an opioid and the non-abuse relevant drug is acetaminophen or ibuprofen. More preferably, the opioid is hydrocodone, and the non-abuse relevant analgesic is acetaminophen. In certain preferred embodiments, the dosage forms are characterized by resistance to solvent extraction; tampering, crushing or grinding. Certain embodiments of the inventions provide dosage forms that provide an initial burst of release of drug followed by a prolonged period of controllable drug release.

    Abstract translation: 本申请中优选的示例性实施方案提供用于递送药物,特别是滥用药物,具有基本上限于核心的滥用相关药物和非核心区域中的非滥用相关药物的制剂和方法。 这些制剂减少了滥用的可能性。 在制剂中,优选滥用相关药物是阿片样物质,非滥用相关药物是对乙酰氨基酚或布洛芬。 更优选地,阿片样物质是氢可酮,非滥用相关镇痛药是对乙酰氨基酚。 在某些优选的实施方案中,剂型的特征在于耐溶剂萃取; 篡改,破碎或研磨。 本发明的某些实施方案提供剂型,其提供药物释放的初始爆发,随后延长药物释放时间。

Patent Agency Ranking